OPKO Health, Inc. Capital Leases, Future Minimum Payments, Present Value of Net Minimum Payments
OPKO Health, Inc. (OPK) had Capital Leases, Future Minimum Payments, Present Value of Net Minimum Payments of $8.90 million as of 2018-12-31, per its 10-K filed 2019-03-01.
Discontinued › Notes › Leases
us-gaap:CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments · last filed 2019-03-01
- 2018-12-31: Capital Leases, Future Minimum Payments, Present Value of Net Minimum Payments $8.90M.
- 2017-12-31: Capital Leases, Future Minimum Payments, Present Value of Net Minimum Payments $11.19M.
- 2016-12-31: Capital Leases, Future Minimum Payments, Present Value of Net Minimum Payments $10.24M.
- 2015-12-31: Capital Leases, Future Minimum Payments, Present Value of Net Minimum Payments $14.66M.
| Period end | Capital Leases, Future Minimum Payments, Present Value of Net Minimum Payments |
|---|---|
| 2018-12-31 | $8.90M 10-K · filed 2019-03-01 |
| 2017-12-31 | $11.19M 8-K · filed 2019-01-29 |
| 2016-12-31 | $10.24M 10-K · filed 2017-03-01 |
| 2015-12-31 | $14.66M 10-K · filed 2016-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |